Related Experiment Video
Updated: Aug 12, 2025

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Targeting and functional effects of biomaterials-based nanoagents for acute pancreatitis treatment
Yujie Cai1, Qian Cao2, Jiannan Li1
1Department of Colorectal and Anal Surgery, The Second Hospital of Jilin University, Changchun, China.
Abstract:
Acute pancreatitis (AP) is a severe life-threatening inflammatory disease showing primary characteristics of excessive inflammatory response and oxidative stress. Based on the pathophysiology of AP, several anti-inflammatory and anti-oxidative stress agents have been studied. However, the low accumulated concentrations and scattered biodistributions limit the application of these agents. With the development of nanotechnology, functional nanomaterials can improve the bioavailability of drugs and extend their half-life by reducing immunogenicity to achieve targeted drug delivery. The biomaterial-based carriers can mediate the passive or active delivery of drugs to the target site for improved therapeutic effects, such as anti-oxidation and anti-inflammation for AP treatment. Other biomaterials-based nanomedicine may exhibit different functions with/without targeting effects. In this review, we have summarized the targeting and functional effects of biomaterials-based nanoagents specifically for AP treatment.
Insights
Biomaterials-based nanoagents offer improved drug delivery for acute pancreatitis (AP) treatment by enhancing bioavailability and targeting. This review summarizes their anti-inflammatory and anti-oxidative effects for AP therapy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Pharmacology
Background:
- Acute pancreatitis (AP) is a severe inflammatory condition characterized by oxidative stress.
- Current treatments are limited by poor drug concentration and biodistribution.
- Nanotechnology offers potential solutions for improved drug delivery in AP.
Purpose of the Study:
- To review the targeting and functional effects of biomaterials-based nanoagents for AP treatment.
- To highlight how nanotechnology can overcome limitations of conventional AP therapies.
- To explore the anti-inflammatory and anti-oxidative roles of nanomedicine in AP.
Main Methods:
- Literature review of studies on biomaterials-based nanoagents for AP.
- Analysis of targeting strategies (passive and active) for drug delivery.
- Evaluation of functional effects, including anti-oxidation and anti-inflammation.
Main Results:
- Biomaterials-based nanoagents can improve drug bioavailability and half-life.
- Targeted delivery enhances therapeutic effects by concentrating agents at the disease site.
- Nanomedicine demonstrates significant anti-inflammatory and anti-oxidative potential for AP.
Conclusions:
- Biomaterials-based nanoagents represent a promising therapeutic strategy for acute pancreatitis.
- Nanotechnology can effectively address drug delivery challenges in AP treatment.
- Further research into functional nanomedicine is crucial for advancing AP therapy.
More Related Videos
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

